About CenExel CIT
CenExel CIT is a Healthcare company based in Santa Ana (United States) founded in 2000, and was acquired by CenExel in March 2021. Clinical trials are conducted by CenExel CIT for medical advancements. It operates on a Professional Services model. CenExel CIT offers products and services including Clinical Trials, Mental Health Studies, Women’s Health Studies, and Youth Studies. Its focus areas include Clinical Research and Trials and Studies. Its legal entity is CenExel Clinical Research. Its competitors include Vial, Javara Research and Alcanza Clinical Research; 2 of its 3 listed competitors have raised funding.
Company details
CenExel CIT, part of CenExel Clinical Research, is engaged in conducting clinical trials across various medical specialties including mental health, womens health, and youth studies. Research is carried out in state-of-the-art facilities to ensure participant safety and comfort. Services are provided to develop future medicines through participant involvement in innovative pharmaceutical research. Operations are supported by board-certified physicians and expertly trained medical staff. Locations in Bellflower and Riverside, United States, are utilized for these research activities.
Products & Services of CenExel CIT
CenExel CIT offers a comprehensive portfolio of products and services, including Clinical Trials, Mental Health Studies, Women’s Health Studies, and Youth Studies.
Clinical trials are conducted for various medical conditions.
Studies on mental health disorders are being conducted.
Research on women’s health issues is being performed.
Clinical studies for youth are currently being offered.
Investors in CenExel CIT
CenExel CIT has secured backing from 1 investor. Prominent investors backing the company include CenExel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Research site management and patient recruitment services are provided. | 2019 | cenexelresearch.com | Salt Lake City, United States |
Investor details for CenExel CIT
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CenExel CIT
2 dated milestones of CenExel CIT across 21 years, from founding to its latest funding, stage changes and deals.
- Founded CenExel CIT is founded.
- Exit Acquired by CenExel.
Competitors of CenExel CIT
CenExel CIT has 3 listed competitors in our database, 2 of them funded. They include Vial, Javara Research and Alcanza Clinical Research.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| vial.com | 2020 | San Francisco, United States | $67M | 65 | Healthcare data capture, clinical trials, and CRO services are provided. | |
| javararesearch.com | 2018 | Winston-salem, United States | $44.98M | Clinical trials for pharmaceuticals are conducted across therapeutic areas. | ||
| alcanzaclinical.com | 2021 | Methuen, United States | Clinical research site network focused on accelerating the development of new therapies by reducing barriers to participation |
Detailed competitors of CenExel CIT
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as CenExel CIT (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CenExel CIT
CenExel CIT was founded in 2000.
CenExel CIT is headquartered in Santa Ana, United States. It is registered at Santa Ana, California, United States.
CenExel CIT, part of CenExel Clinical Research, is engaged in conducting clinical trials across various medical specialties including mental health, womens health, and youth studies. Research is carried out in state-of-the-art facilities to ensure participant safety and comfort. Services are provided to develop future medicines through participant involvement in innovative pharmaceutical research. Operations are supported by board-certified physicians and expertly trained medical staff. Locations in Bellflower and Riverside, United States, are utilized for these research activities.
CenExel CIT's top competitors include Javara Research, Vial and Alcanza Clinical Research.
CenExel CIT offers Clinical Trials, Mental Health Studies, Women’s Health Studies, and Youth Studies.
CenExel CIT has 1 investor. Key investors include CenExel.
CenExel CIT operates through Cenexel Clinical Research.
Yes. CenExel CIT was acquired by CenExel in March 2021.